Genetic Variation Among Lentiviruses: Homology

Total Page:16

File Type:pdf, Size:1020Kb

Genetic Variation Among Lentiviruses: Homology JOURNAL OF VIROLOGY. Sept. 1984. p. 713-721 Vol. 51. No. 3 0022-538X/84/090713-09$02 .00/0 Copyright © 1984, American Society for Microbiology Genetic Variation Among Lentiviruses: Homology Between Visna Virus and Caprine Arthritis-Encephalitis Virus Is Confined to the 5' gag-pol Region and a Small Portion of the env Gene JOANNA M. PYPER, JANICE E. CLEMENTS,* SUSAN M. MOLINEAUX, AND OPENDRA NARAYAN Department of Nelorology, The Johns Hopkins University S( hool oJ Medicine, Btiltitnor-e, Mal-viltnd 21205 Received 27 February 1984/Accepted 4 June 1984 Visna virus of sheep and arthritis-encephalitis virus of goats are serologically related but genetically distinct retroviruses which cause slowly progressive diseases in their natural hosts. To localize homologous regions of the DNAs of these two viruses, we constructed a physical map of caprine arthritis-encephalitis virus DNA and aligned it with the viral RNA. Cloned probes of visna virus DNA were then used to localize regions of homology with the caprine arthritis-encephalitis virus DNA. These studies showed homology in the 5' region of the genome encompassing U5 and the gag and pol genes and also in a small region in the env gene. These findings correlate with biological data suggesting that the regions of the DNA which are homologous may be responsible for virus group characteristics such as the closely related virus core antigens. Regions which did not show homology such as large sections in the env gene may represent unique sequences which control highly strain- specific characteristics such as the neutralization antigen and specific cell tropisms. Lentiviruses of sheep and goats are a distinct group of noncytopathic persistent infection in which virus replication nononcogenic retroviruses which cause slowly progressive is restricted more than 1,000-fold (34). diseases involving the central nervous system, lungs, and To determine the genetic basis for the differences in host joints (8, 9, 12, 13, 17, 35, 43). The lesions are characterized responses to these two viruses, we have begun studies on the by persistent inflammation (active-chronic type) which even- nucleic acids of prototypes of these two virus groups, tually leads to paralysis, respiratory failure, and crippling focusing initially on regions of homology between their arthritis (8, 9, 10, 11). Sheep develop mainly the pneumonic DNAs. Previous hybridization studies have shown that there form of the disease complex, and this leads to neurological is only minor homology between the nucleic acids of visna complications in some animals (17, 35). In goats, the disease virus and CAEV (16, 38). However, the physical location of expression is age dependent with neurological disease occur- homologous and nonhomologous regions between the two ring mainly in young animals and arthritis occurring mainly viral genomes has not been determined. In this study, we in adults (8, 9, 10, 11). The sheep viruses, of which visna is constructed a restriction endonuclease map of the DNA of the prototype, were discovered during epizootics of pneu- CAEV and aligned it with the viral RNA. With cloned moencephalitis (maedi-visna) in Iceland in the 1940s (40. 41), fragments of visna virus DNA (28) and different degrees of and the caprine viruses were discovered during an outbreak stringency for hybridization, we localized regions of nucleic of arthritis and encephalitis among goats in Washington state acid homology and identified regions of the genomes of the in the 1970s (8, 10). These viruses are widespread in sheep two viruses which were distinct. These genetic differences and goat populations in many parts of the world. In experi- and similarities were then compared with the immunological ments, both viruses cause persistent infections and replicate specificities of viral polypeptides determined in immunopre- at a slow but continuous rate for an indefinite period. The cipitation tests and virus neutralization experiments. These continuous release of viral antigens in specific tissues stimu- studies provide new insights into the relationship between lates the inflammatory response which leads to disease. viral genes, gene products, and antiviral host responses and Visna virus and caprine arthritis-encephalitis virus suggest an experimental basis for evaluating the role of viral (CAEV) have different mechanisms for maintaining persis- genes in the outcome of these slow infections. tent replication in their immunocompetent hosts. Both virus- es induce binding antibodies to all their respective polypep- MATERIALS AND METHODS tides during infection. However, they differ greatly with respect to induction of neutralizing antibodies. CAEVs do Virus and cells. CAEV strain CO was used in this study. not induce neutralizing antibodies during natural or experi- The history and characterization of the agent have been mental infections, in contrast to visna viruses, which do so reported previously (8, 29, 33). The virus was plaque purified readily (24, 33). Neutralizing antibodies to visna viruses are and propagated in cultures of goat synovial membrane highly specific. However, the range of neutralization is too (GSM) cells as described earlier (29). Visna virus strain 1514 narrow to inhibit replication of mutant viruses which arise in was used in this study; the plaque-purified virus stock was the immune host. The result of this narrow neutralization grown in sheep choroid plexus cells (SCP) as previously range is selective replication of virus mutants in the persis- described (30, 32). tently infected animal (antigenic drift) (4, 30. 31). These two DNA. GSM or SCP cells were infected at a multiplicity of viruses also vary in their efficiency of replication in sheep infection of 0.5 to 1 and harvested at peak cytopathic effect fibroblasts. Visna viruses cause a highly productive lytic (5 to 7 days postinfection). Low-molecular-weight DNA was infection in these cultures. In contrast, CAEVs cause a isolated as described by Hirt (19), and the supernatant DNA was processed as described by Clements et al. (7) except that * Corresponding author. the RNase A digestion was for 30 min. and digestion with 50 713 714 PYPER ET AL. J. VIROL. pLg of proteinase K per ml-0.5% sodium dodecyl sulfate was Two probes for the U3 region were subcloned into M13mplO substituted for the pronase digestion. from the SstI clone 8.5 and included 8.9 to 9.7 kb (F) and 9.7 Enzymes. Restriction enzymes were purchased from Be- to 10.15 kb (G) from the 5' end of the visna virus DNA. A 5' thesda Research Laboratories, Rockville, Md., or New fragment (0.9 to 1.95 kb from the 5' end of the visna virus England BioLabs, Beverly, Mass., and were used under DNA) from the Sstl 8.5 clone of strain 1514 was also conditions suggested by Maniatis et al. (27). Other pur- subcloned into M13mplO (A). These subclones were labeled chased enzymes were reverse transcriptase (Life Sciences, by using the probe primer (P-L Biochemicals, Inc., Milwau- St. Petersburg, Fla.), RNase-A (Calbiochem-Behring, La kee, Wisc.) and the conditions described by Ricca et al. (36). Jolla, Calif.), and proteinase K (Boehringer-Mannheim Bio- The specific activities of these probes ranged from 7.4 x 106 chemicals, Indianapolis, Ind.). to 1.6 x 107 cpm/[lg. Virus purification. Cells (either GSM cells for CAEV or Agarose gel electrophoresis. DNA was analyzed by electro- SCP cells for visna virus) were infected at a multiplicity of phoresis in 1.2% 3-mm agarose gels, transferred to nitrocel- infection of 0.5 to 1 in 850-cm2 roller bottles (Corning Glass lulose by the method of Southern (42), and hybridized to Works, Corning, N.Y.), and supernatants from the infected different probes under conditions described below. cultures were collected 1 to 2 times per day for 5 to 6 days. Hybridization of probes to DNA transfers. For mapping After clarification of the supernatant fluid at 8,000 rpm in a studies, DNA transfers were hybridized in 50% formamide GSA rotor (Ivan Sorvall, Inc., Norwalk, Conn.) for 30 min, (FLUKA AG) containing 6x SSC, 20 jig of single-stranded the virus was concentrated (100-fold) with a pellicon mem- DNA per ml, 20 jig of tRNA per ml, 50 mM N-2-hydroxyeth- brane concentrator (Millipore Corp., Bedford, Mass.) and ylpiperazine-N'-2-ethanesulfonic acid (pH 7), 0.02% poly- then pelleted at 27,000 rpm in an AH627 rotor (Sorvall) at vinylpyrollidine, and 0.02% bovine serum albumin at 42°C 4°C. The virus was suspended in 0.1 M NaCl-1 mM EDTA- for 36 to 48 h. DNA transfers were washed for 15 min in 2x 20 mM Tris (pH 7.4), diluted 1:1 with 5.3 M NaCl-1 mM SSC at 23°C, 1 h in 1x SSC-0.1% SDS at 50°C, and 2 min in EDTA-20 mM Tris (pH 7.4) (45), incubated at 37°C for 30 1 x SSC at 230C. DNA transfers were air dried and exposed min, and diluted 1:1 with 20 mM Tris (pH 7.4)-i mM EDTA. to Kodak XAR-5 film at -70°C with intensifying screens. Virus was banded by centrifugation for 2 h at 20,000 rpm in a Hybridization conditions used in homology studies were Sorvall SS-90 at 4°C on a step gradient of 55 to 20% sucrose similar to those described by Howley et al. (20). DNA in 1 M NaCI-1 mM EDTA-20 mM Tris (pH 7.4). Virus was transfers were hybridized as for mapping except that the pelleted at 27,000 rpm in an AH627 rotor (Sorvall) and formamide concentration was varied, and hybridization was suspended in 0.1 M NaCl-1 mM EDTA-20 mM Tris (pH 7.4) performed at 350C. Preliminary washes were in 2x SSC for (2,000-fold concentration of original supernatant).
Recommended publications
  • Technical Glossary
    WBVGL 6/28/03 12:00 AM Page 409 Technical Glossary abortive infection: Infection of a cell where there is no net increase in the production of infectious virus. abortive transformation: See transitory (transient or abortive) transformation. acid blob activator: A regulatory protein that acts in trans to alter gene expression and whose activity depends on a region of an amino acid sequence containing acidic or phosphorylated residues. acquired immune deficiency syndrome (AIDS): A disease characterized by loss of cell-mediated and humoral immunity as the result of infection with human immunodeficiency virus (HIV). acute infection: An infection marked by a sudden onset of detectable symptoms usually followed by complete or apparent recovery. adaptive immunity (acquired immunity): See immunity. adjuvant: Something added to a drug to increase the effectiveness of that drug. With respect to the immune system, an adjuvant increases the response of the system to a particular antigen. agnogene: A region of a genome that contains an open reading frame of unknown function; origi- nally used to describe a 67- to 71-amino acid product from the late region of SV40. AIDS: See acquired immune deficiency syndrome. aliquot: One of a number of replicate samples of known size. a-TIF: The alpha trans-inducing factor protein of HSV; a structural (virion) protein that functions as an acid blob transcriptional activator. Its specificity requires interaction with certain host cel- lular proteins (such as Oct1) that bind to immediate-early promoter enhancers. ambisense genome: An RNA genome that contains sequence information in both the positive and negative senses. The S genomic segment of the Arenaviridae and of certain genera of the Bunyaviridae have this characteristic.
    [Show full text]
  • Molecular Characterization of Human Papillomavirus Type 159 (HPV159)
    viruses Article Molecular Characterization of Human Papillomavirus Type 159 (HPV159) Iva Markovi´c 1, Lea Hošnjak 2 , Katja Seme 2 and Mario Poljak 2,* 1 Division of Molecular Biology, Ruder¯ Boškovi´cInstitute, BijeniˇckaCesta 54, 10000 Zagreb, Croatia; [email protected] 2 Institute of Microbiology and Immunology, Faculty of Medicine, University of Ljubljana, Zaloška Cesta 4, 1105 Ljubljana, Slovenia; [email protected] (L.H.); [email protected] (K.S.) * Correspondence: [email protected]; Tel.: +386-1-543-7453 Abstract: Human papillomavirus type 159 (HPV159) was identified in an anal swab sample and preliminarily genetically characterized by our group in 2012. Here we present a detailed molecular in silico analysis that showed that the HPV159 viral genome is 7443 bp in length and divided into five early and two late genes, with conserved functional domains and motifs, and a non-coding long control region (LCR) with significant regulatory sequences that allow the virus to complete its life cycle and infect novel host cells. HPV159, clustering into the cutaneotropic Betapapillomavirus (Beta-PV) genus, is phylogenetically most similar to HPV9, forming an individual phylogenetic group in the viral species Beta-2. After testing a large representative collection of clinical samples with HPV159 type-specific RT-PCR, in addition to the anal canal from which the first HPV159 isolate was obtained, HPV159 was further detected in other muco-cutaneous (4/181, 2.2%), mucosal (22/764, 2.9%), and cutaneous (14/554, 2.5%) clinical samples, suggesting its extensive tissue tropism. However, because very low HPV159 viral loads were estimated in the majority of positive samples, Citation: Markovi´c,I.; Hošnjak, L.; it seemed that HPV159 mainly caused clinically insignificant infections of the skin and mucosa.
    [Show full text]
  • Dissecting Human Antibody Responses Against Influenza a Viruses and Antigenic Changes That Facilitate Immune Escape
    University of Pennsylvania ScholarlyCommons Publicly Accessible Penn Dissertations 2018 Dissecting Human Antibody Responses Against Influenza A Viruses And Antigenic Changes That Facilitate Immune Escape Seth J. Zost University of Pennsylvania, [email protected] Follow this and additional works at: https://repository.upenn.edu/edissertations Part of the Allergy and Immunology Commons, Immunology and Infectious Disease Commons, Medical Immunology Commons, and the Virology Commons Recommended Citation Zost, Seth J., "Dissecting Human Antibody Responses Against Influenza A Viruses And Antigenic Changes That Facilitate Immune Escape" (2018). Publicly Accessible Penn Dissertations. 3211. https://repository.upenn.edu/edissertations/3211 This paper is posted at ScholarlyCommons. https://repository.upenn.edu/edissertations/3211 For more information, please contact [email protected]. Dissecting Human Antibody Responses Against Influenza A Viruses And Antigenic Changes That Facilitate Immune Escape Abstract Influenza A viruses pose a serious threat to public health, and seasonal circulation of influenza viruses causes substantial morbidity and mortality. Influenza viruses continuously acquire substitutions in the surface glycoproteins hemagglutinin (HA) and neuraminidase (NA). These substitutions prevent the binding of pre-existing antibodies, allowing the virus to escape population immunity in a process known as antigenic drift. Due to antigenic drift, individuals can be repeatedly infected by antigenically distinct influenza strains over the course of their life. Antigenic drift undermines the effectiveness of our seasonal influenza accinesv and our vaccine strains must be updated on an annual basis due to antigenic changes. In order to understand antigenic drift it is essential to know the sites of antibody binding as well as the substitutions that facilitate viral escape from immunity.
    [Show full text]
  • Current and Novel Approaches in Influenza Management
    Review Current and Novel Approaches in Influenza Management Erasmus Kotey 1,2,3 , Deimante Lukosaityte 4,5, Osbourne Quaye 1,2 , William Ampofo 3 , Gordon Awandare 1,2 and Munir Iqbal 4,* 1 West African Centre for Cell Biology of Infectious Pathogens (WACCBIP), University of Ghana, Legon, Accra P.O. Box LG 54, Ghana; [email protected] (E.K.); [email protected] (O.Q.); [email protected] (G.A.) 2 Department of Biochemistry, Cell & Molecular Biology, University of Ghana, Legon, Accra P.O. Box LG 54, Ghana 3 Noguchi Memorial Institute for Medical Research, University of Ghana, Legon, Accra P.O. Box LG 581, Ghana; [email protected] 4 The Pirbright Institute, Ash Road, Pirbright, Woking, Surrey GU24 0NF, UK; [email protected] 5 The University of Edinburgh, Edinburgh, Scotland EH25 9RG, UK * Correspondence: [email protected] Received: 20 May 2019; Accepted: 17 June 2019; Published: 18 June 2019 Abstract: Influenza is a disease that poses a significant health burden worldwide. Vaccination is the best way to prevent influenza virus infections. However, conventional vaccines are only effective for a short period of time due to the propensity of influenza viruses to undergo antigenic drift and antigenic shift. The efficacy of these vaccines is uncertain from year-to-year due to potential mismatch between the circulating viruses and vaccine strains, and mutations arising due to egg adaptation. Subsequently, the inability to store these vaccines long-term and vaccine shortages are challenges that need to be overcome. Conventional vaccines also have variable efficacies for certain populations, including the young, old, and immunocompromised.
    [Show full text]
  • Adenoviral Vector-Based Vaccine Platforms for Developing the Next Generation of Influenza Vaccines
    Review Adenoviral Vector-Based Vaccine Platforms for Developing the Next Generation of Influenza Vaccines Ekramy E. Sayedahmed 1 , Ahmed Elkashif 1, Marwa Alhashimi 1, Suryaprakash Sambhara 2,* and Suresh K. Mittal 1,* 1 Department of Comparative Pathobiology, Purdue Institute for Immunology, Inflammation and Infectious Disease, Purdue University Center for Cancer Research, College of Veterinary Medicine, Purdue University, West Lafayette, IN 47907, USA; [email protected] (E.E.S.); [email protected] (A.E.); [email protected] (M.A.) 2 Influenza Division, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA * Correspondence: [email protected] (S.S.); [email protected] (S.K.M.) Received: 2 August 2020; Accepted: 17 September 2020; Published: 1 October 2020 Abstract: Ever since the discovery of vaccines, many deadly diseases have been contained worldwide, ultimately culminating in the eradication of smallpox and polio, which represented significant medical achievements in human health. However, this does not account for the threat influenza poses on public health. The currently licensed seasonal influenza vaccines primarily confer excellent strain-specific protection. In addition to the seasonal influenza viruses, the emergence and spread of avian influenza pandemic viruses such as H5N1, H7N9, H7N7, and H9N2 to humans have highlighted the urgent need to adopt a new global preparedness for an influenza pandemic. It is vital to explore new strategies for the development of effective vaccines for pandemic and seasonal influenza viruses. The new vaccine approaches should provide durable and broad protection with the capability of large-scale vaccine production within a short time. The adenoviral (Ad) vector-based vaccine platform offers a robust egg-independent production system for manufacturing large numbers of influenza vaccines inexpensively in a short timeframe.
    [Show full text]
  • Through a Combination of Continual Antigenic Drift of Surface Proteins and High Transmission Rates the Identity of Circulating I
    Title: Computer-assisted vaccine design Hao Zhou, Ramdas S. Pophale, and Michael W. Deem Departments of Bioengineering and Physics & Astronomy Rice University Houston, TX, USA Abstract We define a new parameter to quantify the antigenic distance between two H3N2 influenza strains: we use this parameter to measure antigenic distance between circulating H3N2 strains and the closest vaccine component of the influenza vaccine. For the data between 1971 and 2004, the measure of antigenic distance correlates better with efficacy in humans of the H3N2 influenza A annual vaccine than do current state of the art measures of antigenic distance such as phylogenetic sequence analysis or ferret antisera inhibition assays. We suggest that this measure of antigenic distance could be used to guide the design of the annual flu vaccine. We combine the measure of antigenic distance with a multiple-strain avian influenza transmission model to study the threat of simultaneous introduction of multiple avian influenza strains. For H3N2 influenza, the model is validated against observed viral fixation rates and epidemic progression rates from the World Health Organization FluNet – Global Influenza Surveillance Network. We find that a multiple-component avian influenza vaccine is helpful to control a simultaneous multiple introduction of bird-flu strains. We introduce Population at Risk (PaR) to quantify the risk of a flu pandemic, and calculate by this metric the improvement that a multiple vaccine offers. Computer-assisted vaccine design Introduction Circulating influenza virus uses the ability to change its surface proteins, along with its high transmission rate, to flummox the adaptive immune response of the host. The random accumulation of mutations in the hemagglutinin (HA) and neuraminidase (NA) epitopes, the regions on surface of the viral proteins that are recognized by host antibodies, pose a formidable challenge to the design of an effective annual flu vaccine.
    [Show full text]
  • Detection of Influenza a Viruses from Environmental Lake and Pond Ice
    TITLE “DETECTION OF INFLUENZA A VIRUSES FROM ENVIRONMENTAL LAKE AND POND ICE” Zeynep A. Koçer A Dissertation Submitted to the Graduate College of Bowling Green State University in partial fulfillment of the requirements for the degree of DOCTOR OF PHILOSOPHY August 2010 Committee: Scott O. Rogers, Advisor W. Robert Midden Graduate Faculty Representative John Castello George Bullerjahn Paul Morris ii ABSTRACT Scott O. Rogers, Advisor Environmental ice is an ideal matrix for the long-term protection of organisms due to the limitation of degradative processes. As a result of global climate change, some glaciers and polar ice fields are melting at rapid rates. This process releases viable microorganisms that have been embedded in the ice, sometimes for millions of years. We propose that viral pathogens have adapted to being entrapped in ice, such that they are capable of infecting naïve hosts after melting from the ice. Temporal gene flow, which has been termed genome recycling (Rogers et al., 2004), may allow pathogens to infect large host populations rapidly. Accordingly, we hypothesize that viable influenza A virions are preserved in lake and pond ice. Our main objective was to identify influenza A (H1-H16) from the ice of a few lakes and ponds in Ohio that have high numbers of migratory and local waterfowl visiting the sites. We developed a set of hemagglutinin subtype-specific primers for use in four multiplex RT-PCR reactions. Model studies were developed by seeding environmental lake water samples in vitro with influenza A viruses and subjecting the seeded water to five freeze-thaw cycles at -20oC and -80oC.
    [Show full text]
  • Antigenic Variation in Vector-Borne Pathogens
    Synopsis Antigenic Variation in Vector-Borne Pathogens Alan G. Barbour* and Blanca I. Restrepo† *University of California Irvine, Irvine, California; and †Corporación para Investigaciones Biológicas, Medellín, Colombia Several pathogens of humans and domestic animals depend on hematophagous arthropods to transmit them from one vertebrate reservoir host to another and maintain them in an environment. These pathogens use antigenic variation to prolong their circulation in the blood and thus increase the likelihood of transmission. By convergent evolution, bacterial and protozoal vector-borne pathogens have acquired similar genetic mechanisms for successful antigenic variation. Borrelia spp. and Anaplasma marginale (among bacteria) and African trypanosomes, Plasmodium falciparum, and Babesia bovis (among parasites) are examples of pathogens using these mechanisms. Antigenic variation poses a challenge in the development of vaccines against vector- borne pathogens. What Is Antigenic Variation? original antigen is archived in the cell and can be Immunodominant antigens are commonly used in the future. The adaptive immune system used to distinguish strains of a species of of an infected vertebrate selects against the pathogens. These antigens can vary from strain original infecting serotype, but that specific to strain to the extent that the strain-specific response is ineffective against new variants. One immune responses of vertebrate reservoirs example of antigenic variation occurs in determine the population structure of the B. hermsii, a cause of tickborne relapsing fever pathogen. One such strain-defining antigen is (4), which has a protein homologous to the OspC the OspC outer membrane protein of the Lyme protein of B. burgdorferi. However, instead of a disease spirochete Borrelia burgdorferi in the single version of this gene, each cell of B.
    [Show full text]
  • Evolution and Adaptation of the Avian H7N9 Virus Into the Human Host
    microorganisms Review Evolution and Adaptation of the Avian H7N9 Virus into the Human Host Andrew T. Bisset 1,* and Gerard F. Hoyne 1,2,3,4 1 School of Health Sciences, University of Notre Dame Australia, Fremantle WA 6160, Australia; [email protected] 2 Institute for Health Research, University of Notre Dame Australia, Fremantle WA 6160, Australia 3 Centre for Cell Therapy and Regenerative Medicine, School of Biomedical Sciences, The University of Western Australia, Nedlands WA 6009, Australia 4 School of Medical and Health Sciences, Edith Cowan University, Joondalup WA 6027, Australia * Correspondence: [email protected] Received: 19 April 2020; Accepted: 19 May 2020; Published: 21 May 2020 Abstract: Influenza viruses arise from animal reservoirs, and have the potential to cause pandemics. In 2013, low pathogenic novel avian influenza A(H7N9) viruses emerged in China, resulting from the reassortment of avian-origin viruses. Following evolutionary changes, highly pathogenic strains of avian influenza A(H7N9) viruses emerged in late 2016. Changes in pathogenicity and virulence of H7N9 viruses have been linked to potential mutations in the viral glycoproteins hemagglutinin (HA) and neuraminidase (NA), as well as the viral polymerase basic protein 2 (PB2). Recognizing that effective viral transmission of the influenza A virus (IAV) between humans requires efficient attachment to the upper respiratory tract and replication through the viral polymerase complex, experimental evidence demonstrates the potential H7N9 has for increased binding affinity and replication, following specific amino acid substitutions in HA and PB2. Additionally, the deletion of extended amino acid sequences in the NA stalk length was shown to produce a significant increase in pathogenicity in mice.
    [Show full text]
  • Recitation 21 – Fall 2018 (Note: the Recitation Summary Should NOT Be Regarded As the Substitute for Lectures) (This Material Is COPYRIGHT Protected.)
    7.016: Fall 2018: MIT 7.016 Recitation 21 – Fall 2018 (Note: The recitation summary should NOT be regarded as the substitute for lectures) (This material is COPYRIGHT protected.) Summary of Lectures 32 (12/3) & 33 (12/5): Viruses: Viruses are obligate intracellular parasites. They consist of a protein coat (capsid) surrounding a genome, which encodes for proteins. These may include structural or coat proteins, other proteins necessary to get inside the host cell and make copies of the viral genome and the proteins that provide the virus with the anti–host defense system. Non-enveloped/ naked viruses do not have a lipid bilayer surrounding their capsid. They typically dock onto a protein on the surface of the target cells and inject their genomes into the host. Enveloped viruses have a lipid bilayer. They fuse their own membrane with the host membrane, such that the entire viral particle is endocytosed into the host cell. Once a virus is inside its host, it takes over the host machinery and uses it to make coat proteins and viral genomes. The genomes are then packaged into the coats and the new viral particles escape from the host cell either by lysing the cell or budding off from the cell. Viral genomes can be composed of either DNA or RNA. They can be single-stranded or double- stranded. There are two types of single stranded RNA viruses: plus (+) stranded or minus (-) stranded. The plus (+) stranded RNA genome can be directly read and translated by the host cell translation machinery. So these viruses bring only their genome, with no additional proteins, into the host cells at the time of infection.
    [Show full text]
  • Perspectives
    PERSPECTIVES in humans. In the 1957 H2N2-SUBTYPE pan- OPINION demic virus, both influenza surface proteins, HA and neuraminidase (NA), and one inter- nal protein, polymerase B1 (PB1), were Evidence of an absence: closely related to Eurasian wild waterfowl influenza proteins6,7.In 1968, the H3N2 pan- the genetic origins of the 1918 demic virus contained novel HA and PB1 proteins, also apparently of Eurasian wild waterfowl origin7,8.Although it is not known pandemic influenza virus exactly how these reassortant viruses were generated, pigs can be infected with both Ann H. Reid, Jeffery K. Taubenberger and Thomas G. Fanning avian and human influenza strains and this species has been suggested as a potential ‘mix- Abstract | Annual outbreaks of influenza A (HA) protein on the virus surface can greatly ing vessel’ for the generation of pandemic infection are an ongoing public health threat reduce the effectiveness of existing antibodies, viruses2,9. and novel influenza strains can periodically leaving people vulnerable to repeated influenza In 1918, the most devastating influenza emerge to which humans have little immunity, infections throughout their lives. In addition pandemic in history killed at least 40 million resulting in devastating pandemics. The 1918 to this gradual change in the influenza virus, people10,11.In addition to a death toll that is pandemic killed at least 40 million people which is known as ANTIGENIC DRIFT, influenza A several times higher than that of other worldwide and pandemics in 1957 and 1968 viruses can acquire novel surface proteins influenza pandemics, the 1918 H1N1 virus caused hundreds of thousands of deaths.
    [Show full text]
  • Drift, Shift, and Attenuation
    Cell, Vol. 104, 469±472, February 23, 2001, Copyright 2001 by Cell Press HIV-1 Sequence Variation: Minireview Drift, Shift, and Attenuation Michael H. Malim*²§ and Michael Emerman³§ that there is an exponentially growing population size *Department of Microbiology (Peeters and Sharp, 2000) and highlights the evolution- ² Department of Medicine ary ªsuccessº of HIV-1 in humans. University of Pennsylvania School of Medicine A second mechanism for acquiring sequence diversity Philadelphia, Pennsylvania 19104 is recombination. This can occur when a cell that is ³ Division of Human Biology dually infected with different viruses produces progeny Fred Hutchinson Cancer Research Center virions with genomic RNAs from each virus, and strand- Seattle, Washington 98109 switching takes place during the next round of reverse transcription (Figure 1b). As increasing numbers of full- length viral sequences become available, the number of recombinant or mosaic viruses that are formed in this The introduction and global dissemination of the retrovi- way from parental viruses of different subtypes is being rus human immunodeficiency virus type-1 (HIV-1) in hu- recognized more frequently. Some of these recombinant mans represents a dramatic and deadly example of re- genomes have themselves become established in the cent genome emergence and expansion; since the human population, and are classified as circulating re- beginning of the pandemic, over 50 million people have combinant forms (CRFs) (McCutchan, 2000; Peeters and been infected and over 16 million of those have died Sharp, 2000). Importantly, and unlike the incremental of AIDS. As with all RNA viruses, HIV-1 replication is accumulation of sequence changes that occurs through characterized by very high mutation rates.
    [Show full text]